Regulation of Microvascular Thromboembolism In Vivo

REFERENCES

• Albrecht E W, Stegeman C A, Heeringa P, Henning R H, van Goor H. Protective role of endothelial nitric oxide synthase. J Pathol 2003; 199: 8–17, [PUBMED]
   PubMed Web of Science ®Google Scholar
• Andre P, Prasad K S, Denis C V, He M, Papalia J M, Hynes R O, Phillips D R, Wagner D D. CD40L stabilizes arterial thrombi by a beta3 integrin—dependent mechanism. Nat Med 2002; 8: 247–252, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Andre P, Delaney S M, LaRocca T, Vincent D, DeGuzman F, Jurek M, Koller B, Phillips D R, Conley P B. P2Y12 regulates platelet adhesion/ activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 2003; 112: 398–406, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Angelillo-Scherrer A, de Frutos P, Aparicio C, Melis E, Savi P, Lupu F, Arnout J, Dewerchin M, Hoylaerts M, Herbert J, Collen D, Dahlback B, Carmeliet P. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001; 7: 215–221, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Augustin H G, Kozian D H, Johnson R C. Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. Bioessays 1994; 16: 901–906, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Azizzadeh B, Buga G M, Berke G S, Larian B, Ignarro L J, Blackwell K E. Inhibitors of nitric oxide promote microvascular thrombosis. Arch Facial Plast Surg 2003; 5: 31–35, [PUBMED], [CSA]
   Google Scholar
• Badimon L. Atherosclerosis and thrombosis: lessons from animal models. Thromb Haemost 2001; 86: 356–365, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Bajzar L. Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway. Arterioscler Thromb Vasc Biol 2000; 20: 2511–2518, [PUBMED]
   PubMed Web of Science ®Google Scholar
• Beguin S, Kumar R, Keularts I, Seligsohn U, Coller B S, Hemker H C. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 1999; 93: 564–570, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Bergqvist D. Haemostatic plug formation in the rabbit mesentery: a methodological study. Ups J Med Sci 1974; 79: 28–38, [PUBMED]
   PubMed Web of Science ®Google Scholar
• Bevers E M, Comfurius P, Zwaal R F. Platelet procoagulant activity: physiological significance and mechanisms of exposure. Blood Rev 1991; 5: 146–154, [PUBMED], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Boegehold M A. Heterogeneity of endothelial function within the circulation. Curr Opin Nephrol Hypertens 1998; 7: 71–78, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Boergen K P, Birngruber R, Hillenkamp F. Laser-induced endovascular thrombosis as a possibility of selective vessel closure. Ophthalmic Res 1981; 13: 139–150
   Google Scholar
• Borgdorff P, Fekkes D, Tangelder G J. Hypotension caused by extracorporeal circulation: serotonin from pump-activated platelets triggers nitric oxide release. Circulation 2002; 106: 2588–2593, [PUBMED], [CROSSREF]
   PubMedGoogle Scholar
• Born G VR. Platelets and blood vessels. J Cardiovasc Pharmacol 1984; 6: S706–S713, [PUBMED]
   Google Scholar
• Brass L. Fifty (or more) ways to leave your platelets (in a thrombus). Arterioscler Thromb Vasc Biol 2004; 24: 989–991, [PUBMED], [CROSSREF]
   Google Scholar
• Breyer R M, Bagdassarian C K, Myers S A, Breyer M D. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001; 41: 661–690, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Broeders M AW, Tangelder G J, Slaaf D W, Reneman R S, oude Egbrink M GA. Endogenous nitric oxide protects against thromboembolism in venules but not in arterioles. Arterioscler Thromb Vasc Biol 1998; 18: 139–145, [PUBMED], [CSA]
   Google Scholar
• Broeders M AW, Doevendans P A, Bekkers B CAM, Bronsaer R, van Gorsel E, Heemskerk J WM, oude Egbrink M GA, van Breda E, Reneman R S, van der Zee R. Nebivolol: a third generation beta-blocker that augments vascular nitric oxide release: endothelial b2-adrenergic receptor-mediated nitric oxide production. Circulation 2000; 102: 677–684, [PUBMED]
   PubMed Web of Science ®Google Scholar
• Broeders M AW, Doevendans P A, Maessen J G, van Gorsel E, oude Egbrink M GA, Daemen M JAP, Tangelder G J, Reneman R S, van der Zee R. The human internal mammary artery releases more nitric oxide in response to vascular endothelial growth factor than the human saphenous vein. J Thorac Cardiovasc Surg 2001; 122: 305–309, [PUBMED], [CROSSREF]
   Google Scholar
• Broeders M AW, Tangelder G J, Slaaf D W, Reneman R S, oude Egbrink M GA. Endogenous nitric oxide and prostaglandins synergistically counteract thromboembolism in arterioles but not in venules. Arterioscler Thromb Vasc Biol 2001; 21: 163–169, [PUBMED]
   Google Scholar
• Broeders M AW, Tangelder G J, Slaaf D W, Reneman R S, oude Egbrink M GA. Hypercholesterolemia enhances thromboembolism in arterioles but not in venules; complete reversal by L-arginine. Arterioscler Thromb Vasc Biol 2002; 22: 680–685, [PUBMED], [CROSSREF]
   Google Scholar
• Busse R, Fleming I. Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces. Trends Pharmacol Sci 2003; 24: 24–29, [PUBMED], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cambien B, Bergmeier W, Saffaripour S, Mitchell H A, Wagner D D. Antithrombotic activity of TNF-alpha. J Clin Invest 2003; 112: 1589–1596, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Cattaneo M, Gachet C. ADP receptors and clinical bleeding disorders. Arterioscler Thromb Vasc Biol 1999; 19: 2281–2285, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Cheng Y, Austin S C, Rocca B, Koller B H, Coffman T M, Grosser T, Lawson J A, FitzGerald G A. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 2002; 296: 539–541, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cines D B, Pollak E S, Buck C A, Loscalzo J, Zimmerman G A, McEver R P, Pober J S, Wick T M, Konkle B A, Schwartz B S, Barnathan E S, McCrae K R, Hug B A, Schmidt A M, Stern D M. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527–3561, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Conley P B, Delaney S M. Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis. Curr Opin Hematol 2003; 10: 333–338, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Coughlin S R. Protease-activated receptors in vascular biology. Thromb Haemost 2001; 86: 298–307, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Davidge S T, Pitt B R, McLaughlin M K, Roberts J M, Johnson B A. Biphasic stimulation of prostacyclin by endogenous nitric oxide (NO) in endothelial cells transfected with inducible NO synthase. Gen Pharmacol 1999; 33: 383–387, [PUBMED], [CROSSREF], [CSA]
   Google Scholar
• de Nucci G, Gryglewski R J, Warner T D, Vane J R. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci USA 1988; 85: 2334–2338, [PUBMED]
   PubMed Web of Science ®Google Scholar
• Denis C, Methia N, Frenette P S, Rayburn H, Ullman-Cullere M, Hynes R O, Wagner D D. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci USA 1998; 95: 9524–9529, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Dörffler-Melly J, Schwarte L A, Ince C, Levi M. Mouse models of focal arterial and venous thrombosis. Basic Res Cardiol 2000; 95: 503–509, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Dorsam R T, Kunapuli S P. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 2004; 113: 340–345, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Falati S, Gross P, Merrill-Skoloff G, Furie B C, Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med 2002; 8: 1175–1181, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Fernandez-Patron C, Martinez-Cuesta M A, Salas E, Sawicki G, Wozniak M, Radomski M W, Davidge S T. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb Haemost 1999; 82: 1730–1735, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Garlanda C, Dejana E. Heterogeneity of endothelial cells; specific markers. Arterioscler Thromb Vasc Biol 1997; 17: 1193–1202, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Gawaz M. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res 2004; 61: 498–511, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gebb S, Stevens T. On lung endothelial cell heterogeneity. Microvasc Res 2004; 68: 1–12, [PUBMED], [CROSSREF]
   Google Scholar
• Gerritsen M E. Physiological and pathophysiological roles of eicosanoids in the microcirculation. Cardiovasc Res 1996; 32: 720–732, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hackeng T M, van 't Veer C, Meijers J C, Bouma B N. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. J Biol Chem 1994; 269: 21051–21058, [PUBMED]
   PubMed Web of Science ®Google Scholar
• Heemskerk J WM, Bevers E M, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002; 88: 186–193, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Hellums J D. 1993 Whitaker Lecture: biorheology in thrombosis research. Ann Biomed Eng 1994; 22: 445–455, [PUBMED]
   Google Scholar
• Ignarro L J. Nitric Oxide: Biology and Pathobiology. Academic Press, San Diego 2000
   Google Scholar
• Inwald D P, McDowall A, Peters M J, Callard R E, Klein N J. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003; 92: 1041–1048, [PUBMED], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ito S, Narumiya S, Hayaishi O. Prostglandin D2: A biochemical perspective. Prostglandins Leukotrienes 1989; Med 37: 219–234, [CROSSREF]
   Google Scholar
• Jackson S P, Nesbitt W S, Kulkarni S. Signaling events underlying thrombus formation. J Thromb Haemost 2003; 1: 1602–1612, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Jang E K, Azzam J E, Dickinson N T, Davidson M M, Haslam R J. Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen-induced platelet aggregation by nitroprusside. Br J Haematol 2002; 117: 664–675, [PUBMED], [CROSSREF], [CSA]
   Google Scholar
• Johnson E N, Brass L F, Funk C D. Increased platelet sensitivity to ADP in mice lacking platelet-type 12-lipoxygenase. Proc Natl Acad Sci USA 1998; 95: 3100–3105, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kawashima S, Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 998–1005, [PUBMED], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Knowles R G, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 249–258, [PUBMED]
   PubMed Web of Science ®Google Scholar
• Kuijpers M J, Schulte V, Bergmeier W, Lindhout T, Brakebusch C, Offermanns S, Fassler R, Heemskerk J W, Nieswandt B. Complementary roles of glycoprotein VI and alpha2beta1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo. FASEB J 2003; 17: 685–687, [PUBMED]
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Dopheide S M, Yap C L, Ravanat C, Freund M, Mangin P, Heel K A, Street A, Harper I S, Lanza F, Jackson S P. A revised model of platelet aggregation. J Clin Invest 2000; 105: 783–791, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Kumada T, Dittman W A, Majerus P W. A role for thrombomodulin in the pathogenesis of thrombin-induced thromboembolism in mice. Blood 1988; 71: 728–733, [PUBMED]
   Google Scholar
• Kurz K D, Main B W, Sandusky G E. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 1990; 60: 269–280, [PUBMED], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Leon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave J P, Gachet C. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor-null mice. J Clin Invest 1999; 104: 1731–1737, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Li Z, Ajdic J, Eigenthaler M, Du X. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans. Blood 2003; 101: 4423–4429, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lindberg R A, Slaaf D W, Miller F N. Involvement of nitric oxide and cyclooxygenase products in photoactivation-induced microvascular occlusion. Mircovasc Res 1994; 47: 203–221, [CROSSREF], [CSA]
   Google Scholar
• Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001; 88: 756–762, [PUBMED]
   PubMed Web of Science ®Google Scholar
• Mann K G, Brummel K, Butenas S. What is all that thrombin for?. J Thromb Haemost 2003; 1: 1504–1514, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Marcus A, Broekman M, Drosopoulos J, Pinsky D, Islam N, Gayle R, 3rd, Maliszewski C. Thromboregulation by endothelial cells: significance for occlusive vascular diseases. Arterioscler Thromb Vasc Biol 2001; 21: 178–182, [PUBMED]
   Google Scholar
• Massberg S, Enders G, Matos F C, Tomic L I, Leiderer R, Eisenmenger S, Messmer K, Krombach F. Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood 1999; 94: 3829–3838, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Massberg S, Gawaz M, Gruner S, Schulte V, Konrad I, Zohlnhofer D, Heinzmann U, Nieswandt B. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 2003; 197: 41–49, [PUBMED], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Massberg S, Gruner S, Konrad I, Garcia Arguinzonis M I, Eigenthaler M, Hemler K, Kersting J, Schulz C, Muller I, Besta F, Nieswandt B, Heinzmann U, Walter U, Gawaz M. Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice. Blood 2004; 103: 136–142, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Massberg S, Konrad I, Bultmann A, Schulz C, Munch G, Peluso M, Lorenz M, Schneider S, Besta F, Muller I, Hu B, Langer H, Kremmer E, Rudelius M, Heinzmann U, Ungerer M, Gawaz M. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J 2004; 18: 397–399, [PUBMED]
   PubMedGoogle Scholar
• Maurice D H, Haslam R J. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol Pharmacol 1990; 37: 671–681, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Mehta S R, Yusuf S. Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. J Am Coll Cardiol 2003; 41: 79S–88S, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Moncada S. Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980: biological importance of prostacyclin. Br J Pharmacol 1982; 76: 3–31, [PUBMED]
   PubMed Web of Science ®Google Scholar
• Moore P K, al-Swayeh O A, Chong N W, Evans R A, Gibson A. L-NG-Nitro arginine L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol 1990; 99: 408–412, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Murray C JL, Lopez A D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349: 1269–1276, [PUBMED], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ni H, Denis C V, Subbarao S, Degen J L, Sato T N, Hynes R O, Wagner D D. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000; 106: 385–392, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Nichols T C, Bellinger D A, Reddick R L, Read M S, Koch G G, Brinkhous K M, Griggs T R. Role of von Willebrand factor in arterial thrombosis: studies in normal and von Willebrand disease pigs. Circulation 1991; 83: IV56–IV64, [PUBMED]
   Google Scholar
• Nowak J, FitzGerald G A. Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man. J Clin Invest 1989; 83: 380–385, [PUBMED]
   PubMed Web of Science ®Google Scholar
• O'Brien J R. Shear-induced platelet aggregation. Lancet 1990; 335: 711–713, [PUBMED], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• oude Egbrink M GA, Tangelder G J, Slaaf D W, Reneman R S. Thromboembolic reaction following wall puncture in arterioles and venules of the rabbit mesentery. Thromb Haemostas 1988; 59: 23–28
   Google Scholar
• oude Egbrink M GA, Tangelder G J, Slaaf D W, Reneman R S. Fluid dynamics and the thromboembolic reaction in mesenteric arterioles and venules. Am J Physiol 1991; 260: H1826–H1833, [PUBMED]
   Google Scholar
• oude Egbrink M GA, Tangelder G J, Slaaf D W, Reneman R S. Different roles of prostaglandins in thromboembolic processes in arterioles and venules in vivo. Thromb Haemostas 1993; 70: 826–833, [CSA]
   Google Scholar
• Palmer R M, Ashton D S, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664–666, [PUBMED], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Paul B Z, Jin J, Kunapuli S P. Molecular mechanism of thromboxane A2-induced platelet aggregation: essential role for p2t(ac) and alpha(2a) receptors. J Biol Chem 1999; 274: 29108–29114, [PUBMED], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pinto A, Sorrentino R, Sorrentino L. Levamisole inhibits in vivo rat platelet aggregation by a release of prostacyclin-like factor. Gen Pharmacol 1990; 21: 255–259, [PUBMED]
   PubMedGoogle Scholar
• Pirich C, Efthimiou Y, O'Grady J, Sinzinger H. Hyperalphalipoproteinemia and prosta glandin I2 stability. Thromb Res 1997; 88: 41–49, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Radomski M W, Palmer R M, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639–646, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Radomski M W, Palmer R M, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92: 181–187, [PUBMED]
   PubMed Web of Science ®Google Scholar
• Reneman R S, Woldhuis B, oude Egbrink M GA, Slaaf D W, Tangelder G J. Concentration and velocity profiles of blood cells in the microcirculation. Advances in cardiovascular engineering, N HC Hwang, V T Turitto, M RT Yen. Plenum Press, New York 1992; 25–40
   Google Scholar
• Resnick N, Yahav H, Shay-Salit A, Shushy M, Schubert S, Zilberman L C, Wofovitz E. Fluid shear stress and the vascular endothelium: for better and for worse. Prog Biophys Mol Biol 2003; 81: 177–199, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Rosen E D, Raymond S, Zollman A, Noria F, Sandoval-Cooper M, Shulman A, Merz J L, Castellino F J. Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi. Am J Pathol 2001; 158: 1613–1622, [PUBMED]
   PubMedGoogle Scholar
• Rosenberg R D, Aird W C. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999; 340: 1555–1564, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Rosenberg R D. Vascular-bed-specific hemostasis and hypercoagulable states: clinical utility of activation peptide assays in predicting thrombotic events in different clinical populations. Thromb Haemost 2001; 86: 41–50, [PUBMED], [CSA]
   Google Scholar
• Ruggeri Z M. Platelets in atherothrombosis. Nat Med 2002; 8: 1227–1234, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ruggeri Z M. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 2003; 1: 1335–1342, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Rumbaut R E, Randhawa J K, Smith C W, Burns A R. Mouse cremaster venules are predisposed to light/dye-induced thrombosis independent of wall shear rate, CD18, ICAM-1, or P-selectin. Microcirculation 2004; 11: 239–247, [PUBMED], [CROSSREF]
   Web of Science ®Google Scholar
• Salvemini D, Currie M G, Mollace V. Nitric oxide-mediated cyclooxygenase activation: a key event in the antiplatelet effects of nitrovasodilators. J Clin Invest 1996; 97: 2562–2568, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Salvemini D. Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol Life Sci 1997; 53: 576–582, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sargeant P, Sage S O. Calcium signalling in platelets and other nonexcitable cells. Pharmacol Ther 1994; 64: 395–443, [PUBMED], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Sato M, Ohshima N. Platelet thrombus induced in vivo by filtered light and fluorescent dye in mesenteric microvasculature of rat. Thromb Res 1984; 35: 319–334, [PUBMED], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schafer A, Schulz C, Eigenthaler M, Fraccarollo D, Kobsar A, Gawaz M, Ertl G, Walter U, Bauersachs J. Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. Blood 2004; 103: 407–412, [PUBMED], [CROSSREF], [CSA]
   Google Scholar
• Seiffge D, Kremer E. Influence of ADP, blood flow velocity, and vessel diameter on the laser-induced thrombus formation. Thromb Res 1986; 42: 331–341, [PUBMED], [CROSSREF]
   Google Scholar
• Selwyn A P. Prothrombotic and antithrombotic pathways in acute coronary syndromes. Am J Cardiol 2003; 91: 3H–11H, [PUBMED], [CROSSREF], [CSA]
   Google Scholar
• Sinzinger H, Rauscha F, Fitscha P, Granegger S. Prevalence of a shortened prostacyclin half-life in plasma in healthy adults: results of a screening investigation. Am J Hematol 1990; 33: 139–141, [PUBMED]
   Google Scholar
• Suzuki H, Swei A, Zweifach B W, Schmid-Schöenbein G W. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: hydroethidine microfluorography. Hypertension 1995; 25: 1083–1089, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Tangelder G J, Teirlinck H C, Slaaf D W, Reneman R S. Distribution of blood platelets flowing in arterioles. Am J Physiol 1985; 248: H318–H323, [PUBMED]
   Google Scholar
• Tangelder G J, Slaaf D W, Muijtjens A AM, Arts T, oude Egbrink M GA, Reneman R S. Velocity profiles of blood platelets and red blood cells flowing in arterioles of the rabbit mesentery. Circ Res 1986; 59: 505–514, [PUBMED]
   PubMed Web of Science ®Google Scholar
• Tangelder G J, Slaaf D W, Arts T, Reneman R S. Wall shear rate in arterioles in vivo: least estimates from platelet velocity profiles. Am J Physiol 1988; 254: H1059–H1064, [PUBMED]
   PubMedGoogle Scholar
• Tangelder G J, oude Egbrink M GA, Slaaf D W, Reneman R S. Blood platelets: an overview. J Reconstr Microsurg 1989; 5: 161–171
   Google Scholar
• Triggle C R, Hollenberg M, Anderson T J, Ding H, Jiang Y, Ceroni L, Wiehler W B, Ng E S, Ellis A, Andrews K, McGuire J J, Pannirselvam M. The endothelium in health and disease—a target for therapeutic intervention. J Smooth Muscle Res 2003; 39: 249–267, [PUBMED]
   PubMedGoogle Scholar
• Uematsu M, Ohara Y, Navas J P, Nishida K, Murphy T J, Alexander R W, Nerem R M, Harrison D G. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol 1995; 269: C1371–C1378, [PUBMED]
   PubMed Web of Science ®Google Scholar
• van Gestel M A, Heemskerk J WM, Slaaf D W, Heijnen V VT, Sage S O, Reneman R S, oude Egbrink M GA. Real-time detection of activation patterns in individual platelets during thromboembolism in vivo: differences between thrombus growth and embolus formation. J Vasc Res 2002; 39: 534–543, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• van Gestel M A, Heemskerk J W, Slaaf D W, Heijnen V V, Reneman R S, oude Egbrink M G. In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability. Arterioscler Thromb Vasc Biol 2003; 23: 518–523, [PUBMED], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• van Gestel M A. Adp and Thrombin During Thromboembolism in Vivo: a Vital Imaging Approach. Maastricht University. 2004, Thesis
   Google Scholar
• van Hinsbergh V W. The endothelium: vascular control of haemostasis. Eur J Obstet Gynecol Reprod Biol 2001; 95: 198–201, [PUBMED], [CROSSREF], [CSA]
   Google Scholar
• Vandeplassche G, Bernier M, Thone F, Borgers M, Kusama Y, Hearse D J. Singlet oxygen and myocardial injury: ultrastructural, cytochemical and electrocardiographic consequences of photoactivation of rose bengal. J Mol Cell Cardiol 1990; 22: 287–301, [PUBMED], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Vane J R, Botting R M. Pharmacodynamic profile of prostacyclin. Am J Cardiol 1995; 75: 3a–10a, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Vink H, Constantinescu A A, Spaan J A. Oxidized lipoproteins degrade the endothelial surface layer : implications for platelet-endothelial cell adhesion. Circulation 2000; 101: 1500–1502, [PUBMED]
   PubMed Web of Science ®Google Scholar
• Wade M L, Fitzpatrick F A. Nitric oxide modulates the activity of the hemoproteins prostaglandin I2 synthase and thromboxane A2 synthase. Arch Biochem Biophys 1997; 347: 174–180, [PUBMED], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Wagner L, Hoey J G, Erdely A, Boegehold M A, Baylis C. The nitric oxide pathway is amplified in venular vs arteriolar cultured rat mesenteric endothelial cells. Microvasc Res 2001; 62: 401–409, [PUBMED], [CROSSREF], [CSA]
   Google Scholar
• Woldhuis B, Tangelder G J, Slaaf D W, Reneman R S. Concentration profile of blood platelets differs in arterioles and venules. Am J Physiol 1992; 262: H1217–H1223, [PUBMED]
   Google Scholar
• Wu K K, Chen Y C, Fordham E, Ts'Ao C H, Rayudu G, Matayoshi D. Differential effects of two doses of aspirin on platelets-vessel wall interaction in vivo. J Clin Invest 1981; 68: 382–387, [PUBMED]
   Google Scholar
• Yang Z, Arnet U, Bauer E, von Segesser L, Siebenmann R, Turina M, Luscher T F. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction: role of prostacyclin, nitric oxide, and thromboxane A2. Circulation 1994; 89: 2266–2272, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar
• Ziegler T, Silacci P, Harrison V J, Hayoz D. Nitric oxide synthase expression in endothelial cells exposed to mechanical forces. Hypertension 1998; 32: 351–355, [PUBMED], [CSA]
   PubMed Web of Science ®Google Scholar